ARTICLE | Clinical News
CPC-111: Began a Phase II trial
December 19, 1994 8:00 AM UTC
Cypros Pharmaceutical Corp. (CYPR), Carlsbad, Calif. Product: CPC-111 small molecule that acts to generate adenosine triphosphate in the absence of oxygen, maintaining cellular energy; also decreases ...